These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34121244)

  • 1. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
    Campos-Varela I; Len O; Villagrasa A; Márquez-Algaba E; Esperalba J; Dopazo C; Los-Arcos I; Antón A; Castells L
    Transpl Int; 2021 Oct; 34(10):1908-1913. PubMed ID: 34121244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study.
    Rauber C; Tiwari-Heckler S; Pfeiffenberger J; Mehrabi A; Lund F; Gath P; Mieth M; Merle U; Rupp C
    Transplant Proc; 2021 May; 53(4):1112-1117. PubMed ID: 33451759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.
    Mrzljak A; Jureković Ž; Pavičić-Šarić J; Stevanović V; Tabain I; Hruškar Ž; Mikulić D; Barbić L; Vilibić-Čavlek T
    Biochem Med (Zagreb); 2021 Oct; 31(3):030901. PubMed ID: 34658649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower seroprevalence for SARS-CoV-2-specific antibodies among kidney transplant recipients compared to the general population in the city of Sao Paulo, Brazil.
    Cristelli MP; Viana LA; Fortaleza CM; Granato C; Nakamura MR; Santos DWCL; Foresto RD; Tedesco-Silva H; Medina-Pestana J
    Transpl Infect Dis; 2021 Oct; 23(5):e13706. PubMed ID: 34322975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
    Kaddu-Mulindwa D; Keuser L; Lesan V; Rissland J; Smola S; Werdecker V; Stilgenbauer S; Christofyllakis K; Thurner L; Bewarder M; Lohr B; Lutz J; Lohse S; Rieke A
    HIV Med; 2022 May; 23(5):564-569. PubMed ID: 34811869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral response to SARS-CoV-2 is well preserved and symptom dependent in kidney transplant recipients.
    Magicova M; Fialova M; Zahradka I; Rajnochova-Bloudickova S; Hackajlo D; Raska P; Striz I; Viklicky O
    Am J Transplant; 2021 Dec; 21(12):3926-3935. PubMed ID: 34212497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral response to SARS-CoV-2 infection among liver transplant recipients.
    Becchetti C; Broekhoven AGC; Dahlqvist G; Fraga M; Zambelli MF; Ciccarelli O; Saouli AC; Trizzino A; Banz V; Dufour JF; Roukens AHE; Torres Morales SP; Myeni SK; Kikkert M; Feltkamp MCW; Coenraad MJ
    Gut; 2022 Apr; 71(4):746-756. PubMed ID: 34987065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
    Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
    BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.
    Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C
    BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 seroprevalence in children and their family members, July-October 2020, Brussels.
    Dethioux L; Dauby N; Montesinos I; Rebuffat E; Hainaut M
    Eur J Pediatr; 2022 Mar; 181(3):1009-1016. PubMed ID: 34677664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients.
    Citores MJ; Caballero-Marcos A; Cuervas-Mons V; Alonso-Fernández R; Graus-Morales J; Arias-Milla A; Valerio M; Muñoz P; Salcedo M
    J Microbiol Immunol Infect; 2023 Jun; 56(3):526-536. PubMed ID: 36964052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study.
    Seck SM; Mbow M; Kane Y; Cisse MM; Faye G; Kama A; Sarr M; Nitcheu P; Dahaba M; Diallo IM; Diawara MS; Latou LNM; Dia Y; Mboup S
    BMC Nephrol; 2021 Nov; 22(1):384. PubMed ID: 34789170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening.
    Willicombe M; Gleeson S; Clarke C; Dor F; Prendecki M; Lightstone L; Lucisano G; McAdoo S; Thomas D;
    Transplantation; 2021 Jan; 105(1):151-157. PubMed ID: 33196625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.